German Telecom Services and Carriers Stock News

XTRA:NDX1
XTRA:NDX1Electrical

Nordex (XTRA:NDX1) Valuation Check After Fresh Wind Farm Orders And Contract Momentum

The recent run in Nordex (XTRA:NDX1) has coincided with fresh contract momentum, including a 35 MW wind farm order in Germany and new projects in Serbia and across its German home market. See our latest analysis for Nordex. These contract wins come alongside a clear upswing in market sentiment, with a 30 day share price return of 8.32% and a 1 year total shareholder return of 211.55% pointing to strong momentum around Nordex. If you are looking for other ways to put the energy transition...
XTRA:P911
XTRA:P911Auto

Assessing Porsche (XTRA:P911) Valuation After Mixed Recent Returns And Margin Recovery Expectations

Recent performance and context for Dr. Ing. h.c. F. Porsche (XTRA:P911) With no single headline event driving attention, Dr. Ing. h.c. F. Porsche (XTRA:P911) has still been drawing interest as investors weigh mixed recent returns against its current valuation and operating profile. See our latest analysis for Dr. Ing. h.c. F. Porsche. At a share price of €39.55, the stock has seen a 5.02% 7 day share price return but a 16.91% decline year to date. The 1 year total shareholder return of 7.40%...
XTRA:ADS
XTRA:ADSLuxury

Is adidas (XTRA:ADS) Starting To Look Attractive After A 49% Five Year Share Price Slide?

Wondering whether adidas at €134.90 is starting to look like value or still has more room to fall? This article breaks down what that price really implies about the stock. Over the last week the share price is up 0.6%, but over the last month it is down 8.3% and year to date it is down 19.4%, adding to a 30.2% decline over the last year and a 49.0% decline over five years. These moves sit against a backdrop of continuing focus on adidas as a major global sportswear brand, with investors...
XTRA:KSB
XTRA:KSBMachinery

A Look At KSB SE KGaA (XTRA:KSB) Valuation After Dividend Affirmation And Full Year Results

Dividend affirmation and earnings update reshape the picture for KSB SE KGaA KSB SE KGaA (XTRA:KSB) updated investors with full year 2025 results and confirmed an annual dividend of €26.50 per share, a combination that puts income and earnings trends in clearer focus. See our latest analysis for KSB SE KGaA. The dividend confirmation and full year results arrived after a mixed run for the shares, with a 6.48% 1 month share price return decline, a 4.12% 3 month share price return, and a 31.91%...
XTRA:LHA
XTRA:LHAAirlines

Assessing Lufthansa (XTRA:LHA) Valuation As Share Momentum Softens And Fair Value Edges Higher

Recent share performance and business snapshot Deutsche Lufthansa (XTRA:LHA) has seen mixed share performance recently, with a 3.4% decline over the past day and a 9.2% decline over the past month, alongside a 12.6% decline over the past 3 months. At a recent close of €7.50 and a market value of about €9.0b, the group operates passenger airlines, cargo logistics, and aircraft maintenance, repair and overhaul services across multiple regions. See our latest analysis for Deutsche...
XTRA:LXS
XTRA:LXSChemicals

Lanxess Price Moves And Bank Of America Stake Meet Valuation Debate

Lanxess (XTRA:LXS) has announced price increases for its sulfur based products in response to ongoing market and cost pressures. Bank of America has disclosed that it now holds over 5% of voting rights in Lanxess AG, crossing a key ownership threshold. Lanxess, a specialty chemicals producer, is active across sectors such as industrial manufacturing, agriculture, and consumer goods, where sulfur based products play an important role in multiple value chains. Price adjustments in this...
XTRA:NEM
XTRA:NEMSoftware

European Stocks Possibly Trading Below Estimated Value In April 2026

As European markets navigate the complexities of Middle East tensions and energy market volatility, the pan-European STOXX Europe 600 Index has shown resilience, ending a recent week with a notable gain of 3.92%. Amid these fluctuations, investors may find opportunities in stocks that appear to be trading below their estimated value, particularly as inflationary pressures and economic forecasts continue to shape the investment landscape. Identifying potentially undervalued stocks often...
XTRA:G24
XTRA:G24Interactive Media and Services

Does Scout24’s Dividend and Buyback Push Reshape Its Capital Allocation Story (XTRA:G24)?

Scout24 SE has announced an annual dividend of €1.50 per share payable on June 22, 2026, alongside an ongoing share buy-back programme that has retired 1,039,926 shares between January 5 and March 27, 2026. Together with Amundi S.A.’s voting stake slipping just below 5%, these capital-return moves highlight shifting ownership and management’s focus on rewarding shareholders. With Scout24 coupling its dividend with ongoing buy-backs, we’ll now examine how this capital return focus shapes the...
XTRA:DTE
XTRA:DTETelecom

Is Deutsche Telekom (XTRA:DTE) Pricing Look Attractive After Recent Share Price Weakness?

If you are wondering whether Deutsche Telekom at €30.77 is still fairly priced or offers room for value, this article walks through what the numbers actually say. The stock has seen a 3.7% decline over the last week and a 5.7% decline over the last month, while the 1 year return sits at a 3.7% decline and the 3 year and 5 year returns are 49.8% and 117.8% respectively. This may change how you think about risk and reward at today’s level. Recent coverage has focused on Deutsche Telekom in the...
XTRA:IFX
XTRA:IFXSemiconductor

A Look At Infineon Technologies (XTRA:IFX) Valuation After Recent Share Price Volatility

Infineon Technologies in focus Infineon Technologies (XTRA:IFX) is back on investors’ radar after recent share price volatility, with the stock showing mixed short term returns and a last close of €38.96 on the Xetra exchange. See our latest analysis for Infineon Technologies. The recent 1 day share price decline of 2.96% comes after a softer 30 day share price return of 6.53% and a modest 1.82% year to date gain, while the 1 year total shareholder return of 39.39% points to momentum that has...
XTRA:DBK
XTRA:DBKCapital Markets

A Look At Deutsche Bank (XTRA:DBK) Valuation As APAC Leadership Shift Aligns With New Bond And Pfandbrief Activity

Deutsche Bank (XTRA:DBK) is back in focus after appointing Joe Lai as head of investment banking and capital markets for Asia-Pacific, alongside a series of new bond issues and active management of its existing Pfandbriefe. See our latest analysis for Deutsche Bank. The share price has been under pressure recently, with a 30 day share price return of an 8.27% decline and a 90 day share price return of a 23.50% decline. This comes as recent executive appointments in Asia Pacific and ongoing...
XTRA:8TRA
XTRA:8TRAMachinery

Assessing Traton (XTRA:8TRA) Valuation After TRATON ONE OS Technology Launch

TRATON ONE OS announcement and why it matters for Traton (XTRA:8TRA) shareholders Traton (XTRA:8TRA) has drawn fresh attention after announcing TRATON ONE OS with Applied Intuition, a shared software platform intended to support predictive maintenance, over the air updates, and future autonomous driving capabilities across its truck brands. See our latest analysis for Traton. Against this backdrop, Traton’s share price has been relatively steady, with a 3.01% 7 day share price return and a...
XTRA:FPE3
XTRA:FPE3Chemicals

Will Dividend Hike and OPET Deal Recast Fuchs' (XTRA:FPE3) Capital Allocation Narrative?

Fuchs SE recently reported full-year 2025 results showing sales of €3,563 million and net income of €306 million, alongside 2026 guidance calling for around €3.7 billion in sales and €450 million in EBIT, supported in part by the planned full acquisition of its Turkish OPET joint venture. The company also proposed and later announced a 5% increase in the dividend to €1.23 per preference share, with the annual payout of €1.23 per share scheduled for payment on May 11, 2026, underlining a...
XTRA:SIE
XTRA:SIEIndustrials

Siemens Division Reorganisation Puts Focus On Valuation And Debt Risks

Siemens, ticker XTRA:SIE, is planning a reorganisation of two divisions to refine its operational setup. The move signals a change in how the group is structured, with potential effects on future business priorities. This shift follows earlier attention on leadership changes and manufacturing investments, and focuses on internal alignment rather than new projects. For investors watching XTRA:SIE, the planned reorganisation comes as the share price stands at €215.35. The stock has seen a...
XTRA:R3NK
XTRA:R3NKMachinery

3 European Value Stocks Trading Up To 49.9% Below Intrinsic Estimates

The European market has been navigating a complex landscape, with the STOXX Europe 600 Index showing modest gains amid ongoing geopolitical tensions and fluctuating energy prices. As investors assess these challenges, identifying stocks trading below their intrinsic value can offer potential opportunities for those seeking to capitalize on market inefficiencies.
XTRA:ZAL
XTRA:ZALSpecialty Retail

Zalando (XTRA:ZAL) Valuation Check As AI Leader Peter Sarlin Joins The Board

Zalando (XTRA:ZAL) is back in focus after the supervisory board put forward AI specialist Peter Sarlin, founder of Silo AI, for election. The move underlines a push to embed advanced data and automation across its platform. See our latest analysis for Zalando. The AI-focused board nomination comes after a mixed share price run, with a 7.11% 1 month share price return contrasting with a 16.18% 3 month decline and a 36.45% 1 year total shareholder return loss. This suggests sentiment has...
XTRA:KTA
XTRA:KTAAuto

Knaus Tabbert Q3 Loss Of €14.7 Million Tests Earnings Recovery Narratives

Knaus Tabbert (XTRA:KTA) has just posted another tough set of FY 2025 numbers, with Q3 revenue of €190.8 million and a net loss of €14.7 million, following Q2 revenue of €278.8 million and a marginal net loss of €0.1 million alongside basic EPS of €0.01 loss per share. The company has seen revenue move between €296.2 million in Q1 2025 and €195.6 million in Q4 2024, while basic EPS has ranged from €0.44 loss per share in Q1 2025 to €4.88 loss per share in Q4 2024. This sets the scene for...
XTRA:AFX
XTRA:AFXMedical Equipment

Carl Zeiss Meditec (XTRA:AFX) Valuation After Expanded Canadian Ophthalmology Workflow Suite

Carl Zeiss Meditec (XTRA:AFX) is back in focus after announcing an expanded suite of ophthalmology and optometry workflow solutions in Canada, including diagnostic platforms, therapeutic lasers, and subscription-based digital data management tools. See our latest analysis for Carl Zeiss Meditec. Despite the product expansion and recent index changes, the 1 day share price return of 2.89% to €24.9 sits against a 90 day share price return decline of 37.75% and a 1 year total shareholder return...
XTRA:SHL
XTRA:SHLMedical Equipment

Assessing Siemens Healthineers (XTRA:SHL) Valuation After Recent Weak Share Performance

Recent share performance and business profile Siemens Healthineers (XTRA:SHL) has drawn attention after a stretch of weaker share performance, with the stock showing negative returns over the past month, past 3 months, year to date, and over the past year. That market reaction sits against a sizeable healthcare technology business, with revenue of €23.295b and net income of €2.119b across imaging, diagnostics, cancer care, and advanced therapies segments serving hospitals and clinics...
XTRA:ACT
XTRA:ACTChemicals

European Insiders Back These 3 Growth Stocks For Strong Potential

As the European markets navigate uncertainty from geopolitical tensions and fluctuating energy prices, investors are increasingly focused on companies with strong growth potential and significant insider ownership. In this environment, stocks backed by insiders can be appealing as they often signal confidence in the company's future prospects.
XTRA:BAYN
XTRA:BAYNPharmaceuticals

Is There Still Opportunity In Bayer (XTRA:BAYN) After Its 88% One Year Surge?

Wondering if Bayer at €40.12 is still offering value after such a strong run, or if most of the opportunity is already priced in. The stock has returned 5.2% over the last 7 days and 5.6% year to date, while the 1 year return sits at 88.2% against a 3 year return of 29.2% and a 5 year return of 15.5%. Recent headlines have focused on Bayer's ongoing portfolio and operational decisions, as well as its efforts to address legal exposures that have been closely watched by the market. This...